The changes cover how topics are chosen, the steps and stages in each evaluation and how evidence is...
Read moreThe report looks at four possible scenarios including most notably the creation of a “grande Sécu...
Read moreThe Court has annulled the inclusion of the orphan drug Onivyde (irinotecan) in the reference price ...
Read moreThe association proposes concentrating efforts around four primary objectives.
Read moreIn addition to new cancer drugs, the G-BA also evaluated the first antiviral drug to treat COVID-19 ...
Read moreNotably, the early access scheme was reformed with effect from 1st July 2021.
Read moreThe National Institute for Health and Care Excellence (NICE) on 31st January 2022 published its new ...
Read moreThe Ministry of Health reports that 65.1% of medicines admitted to reimbursement in 2021 were subjec...
Read moreThe 2021 Social Security Law made provision for overhauling the early scheme in France. As of 1st Ju...
Read moreWe hope you’ve had a wonderful start to the New Year and we’d love to welcome you to our fourth ...
Read more